AMS is pleased to announce that the United States Food and Drug Administration ("FDA") has cleared the 510(k) submission for the LIASYS(TM) bench top clinical chemistry and immunoturbidimetric analyzer. The analyzer is on show at the 2008 Annual Meeting for the American Association for Clinical Chemistry ("AACC") currently being held in Washington D.C. A broad range of dedicated reagents have been optimized and validate for LIASYS. This makes LIASYS an attractive chemistry analyzer that offers an excellent combination of sampling speed, precision, reliability, and ease of use.
LIASYS is a fully automatic random access, continuous loading, easy access bench top clinical chemistry and immunoturbidimetric analyzer. The instrument features primary tubes sampling, capacitive liquid level sensing, positive identification of the samples, and module for ion selective electrode ("ISE"). It is suitable to perform the daily routine of low/medium-sized laboratories in an entirely safe and reliable way, providing flexible and cost effective solutions. The LIASYS multitasking and user-friendly software enhances the system's potential and performance.
